-+ 0.00%
-+ 0.00%
-+ 0.00%

Vertex CSO Mark E. Bunnage sells 33 shares for $14,963.85

PUBT·05/19/2026 20:05:47
Listen to the news
Vertex CSO Mark E. Bunnage sells 33 shares for $14,963.85
  • Vertex Pharmaceuticals EVP and Chief Scientific Officer Mark E. Bunnage sold 33 shares of common stock on May 15 at USD 453.45.
  • His direct holdings stood at 7,284 shares following the transaction.
  • The sale was executed under a Rule 10b5-1 trading plan adopted on Nov. 26, 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vertex Pharmaceuticals Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000875320-26-000226), on May 19, 2026, and is solely responsible for the information contained therein.